MarketPeel
Insider Trading Intelligence
EK

Eliyahu Sharon Kalif

TEVA
EVP, CHIEF FINANCIAL OFFICER · TEVA PHARMACEUTICAL INDUSTRIES LTD · CIK 0001798443
FILING MIX · LIFETIME53%/47%
BUYS
37
SELLS
33
TOTAL VALUE
$24.53M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
65,621
AVG SELL PX
$27.71
TRADE KIND
SHOWING 70 / 70
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 5 pending
Forward-return performance of every backtestable P/S trade by Eliyahu Sharon Kalif, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+83.33%-3.96%-1.21%-2.75%-3.12%
14d6+100.00%-5.85%-2.15%-3.70%-5.32%
30d6+83.33%-7.37%-2.93%-4.44%-3.97%
60d6+83.33%-5.88%-1.52%-4.35%-3.38%
90d6+33.33%+3.88%+0.90%+3.27%+2.48%
180d6(1 pending)+20.00%+26.87%+8.24%+18.63%+17.00%
1y6(1 pending)+20.00%+56.92%+15.40%+41.53%+58.13%
2y6(3 pending)+0.00%+91.39%+39.16%+52.24%+38.67%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TEVA · 65,621 shares · as of Jun 11, 2026
0114,766229,532344,297459,063202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 37 buys / 33 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
106,563$34.10$3.63M65,621Jun 11, 2026Jun 16, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
153,251$35.61$5.46M172,184May 14, 2026May 18, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
19,91659,748Mar 5, 2026Mar 9, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
19,916325,435Mar 5, 2026Mar 9, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
23,25146,503Mar 4, 2026Mar 6, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
33,512282,268Mar 4, 2026Mar 6, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
53,17553,175Mar 4, 2026Mar 6, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
33,5120Mar 4, 2026Mar 6, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
23,251305,519Mar 4, 2026Mar 6, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
49,80049,802Mar 3, 2026Mar 5, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
49,800107,278Mar 3, 2026Mar 5, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
141,478248,756Mar 3, 2026Mar 5, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
141,4780Mar 3, 2026Mar 5, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
345,810$33.64$11.63M57,478Feb 26, 2026Mar 2, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
141,478141,478Jan 27, 2026Jan 29, 2026View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
55,775$17.08$952.5K403,288Jun 12, 2025Jun 16, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
21,3900Mar 5, 2025Mar 7, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
21,390459,063Mar 5, 2025Mar 7, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
79,66479,664Mar 5, 2025Mar 7, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
23,25169,754Mar 4, 2025Mar 6, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
183,169437,673Mar 4, 2025Mar 6, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
33,51233,512Mar 4, 2025Mar 6, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
33,512231,253Mar 4, 2025Mar 6, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
23,251254,504Mar 4, 2025Mar 6, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
183,1690Mar 4, 2025Mar 6, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
49,80099,602Mar 3, 2025Mar 4, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
49,800197,741Mar 3, 2025Mar 4, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
55,750$16.21$903.5K147,941Feb 28, 2025Mar 4, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
183,169183,169Jan 28, 2025Jan 30, 2025View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE10b5-1
10b5-1 plan
77,550$13.52$1.05M203,691Mar 6, 2024Mar 7, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
21,387281,241Mar 5, 2024Mar 7, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
52,320259,854Mar 5, 2024Mar 7, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
21,38721,390Mar 5, 2024Mar 7, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
52,3200Mar 5, 2024Mar 7, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
33,512207,534Mar 4, 2024Mar 5, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
93,00593,005Mar 4, 2024Mar 5, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
33,512207,534Mar 4, 2024Mar 5, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
49,800174,022Mar 3, 2024Mar 5, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
49,800174,022Mar 3, 2024Mar 5, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
18,430124,222Feb 28, 2024Mar 1, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
18,4300Feb 28, 2024Mar 1, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
6,6300Feb 13, 2024Feb 15, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
6,630105,792Feb 13, 2024Feb 15, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
52,32052,320Jan 30, 2024Feb 1, 2024View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
35,125$9.73$341.9K99,162Aug 7, 2023Aug 9, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
21,38742,777Mar 5, 2023Mar 7, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
21,387134,287Mar 5, 2023Mar 7, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
33,512112,900Mar 4, 2023Mar 7, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
33,512100,536Mar 4, 2023Mar 7, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
199,202199,202Mar 3, 2023Mar 7, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
44,9530Feb 28, 2023Mar 2, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
44,95379,388Feb 28, 2023Mar 2, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
18,43034,435Feb 28, 2023Mar 2, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
18,43018,430Feb 28, 2023Mar 2, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
6,62916,005Feb 13, 2023Feb 15, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
6,6296,630Feb 13, 2023Feb 15, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
44,95344,953Feb 7, 2023Feb 9, 2023View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
55,500$10.07$558.7K9,376Aug 22, 2022Aug 24, 2022View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
21,38764,876Mar 5, 2022Mar 8, 2022View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
21,38764,164Mar 5, 2022Mar 8, 2022View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
134,048134,048Mar 4, 2022Mar 8, 2022View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
18,43036,860Feb 28, 2022Mar 2, 2022View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
18,43043,489Feb 28, 2022Mar 2, 2022View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
6,62913,259Feb 13, 2022Feb 15, 2022View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
6,62925,059Feb 13, 2022Feb 15, 2022View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
85,55185,551Mar 5, 2021Mar 8, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SALE
EVP, Chief Financial Officer
18,43055,290Feb 28, 2021Mar 2, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASE
EVP, Chief Financial Officer
18,43018,430Feb 28, 2021Mar 2, 2021View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
73,72073,720Feb 28, 2020Mar 3, 2020View →
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
PURCHASEGRANT
Stock grant
19,88819,888Feb 13, 2020Feb 18, 2020View →
Other insiders · TEVA
Loading peer insiders…
About this filer
CIK 0001798443
ROLE
EVP, Chief Financial Officer
PRIMARY
TEVA
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001798443DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback